Key facts
- NOCD’s last known valuation is $268.7M.
- It has raised $90.0M; the latest was Later Stage VC ($5.7M) in Aug 2024.
- Notable investors include F-Prime Capital, Eight Roads, Hyde Park Angels, Longitude Capital, Chicago Ventures — 16 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for NOCD
- ·The full record, as it builds
Funding rounds
No funding rounds for NOCD are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About NOCD
Developer of a telehealth application designed to assist in the self-treatment and monitoring of obsessive-compulsive disorder symptoms. The company's application guides patients through exposure and response prevention exercises and therapy that is especially effective for obsessive-compulsive disorder, enabling clinicians and researchers to improve obsessive-compulsive disorder treatment and connect with patients.
- Sector
- Healthcare
- HQ
- Chicago, IL, United States
- Founded
- 2014
- Employees
- 475
- Website
- treatmyocd.com/
- Ownership
- Privately Held (backing)
NOCD doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NOCD shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NOCD in its N-PORT filings yet. We sweep new filings monthly.